Evidence
Ugeskr Laeger. 2023 May 22;185(21):V09220529.
ABSTRACT
Opioid use disorders can be treated with psychosocial interventions which aim to increase quality of life and minimize problems maintaining drug use. In addition, pharmacological treatment with opioid maintenance therapy (OMT) can help minimize morbidity and mortality. The principle for OMT is substituting to another opioid with a more favourable pharmacological profile, primarily buprenorphine or methadone. The first choice is buprenorphine in combination with naloxone. The aim of this review is to summarize current principles for handling patients in OMT.
PMID:37264884
Add to Google Keep
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Municipal offers and principles for substitution treatment for abuse and addiction to opioids
🌐 90 Days
VR Related Evidence Matrix
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- Methadone Withdrawal-Induced Psychosis: A Case Report
- Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder
- Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
- Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults
- Opioid-free anesthesia : Wrong track or meaningful exit from the era of opioid-based analgesia?
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation
- Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation
- Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence
- Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022
- A qualitative study of experiences with physical activity among people receiving opioid agonist therapy
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives
- Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency
- Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients
- Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy
- Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy
- Opioid use and risks in liver transplant candidates and recipients
- The development and internal validation of a multivariable model predicting 6-month mortality for people with opioid use disorder presenting to community drug services in England: a protocol
- Impact of opioid maintenance therapy in the community on reincarceration in individuals with opioid use disorder-A linked cohort study
- What are the effects of pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, in the treatment of post-stroke depression? A Cochrane Review summary with commentary
- Buprenorphine Affects the Initiation and Severity of Interleukin Induced Acute Pancreatitis in Mice
- An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report
- Deaddicta® for maintenance treatment of Opioid-dependence: A six-month follow-up
- National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings
- Xylazine: A Drug Adulterant of Clinical Concern
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting
- Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia
- Peptide-derived ligands for the discovery of safer opioid analgesics
- A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets
- Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study
- Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study
- Managing the Patient with Psoriasis and Metabolic Comorbidities
- Time trends in opioid use for patients undergoing hip fracture surgery in 1997-2018: A Danish population-based cohort study
- Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype
- Comparison of Medical Therapy, Valve Surgery and Percutaneous Mechanical Aspiration for Tricuspid Valve Infective Endocarditis
- The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
- Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction)
- Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction)
- The sociodemographic profile and the challenges associated with treatment and rehabilitation in female heroin users: A case series from Northeast India
- Machine learning identifies risk factors associated with long-term opioid use in fibromyalgia patients newly initiated on an opioid
- Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians
- Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients
- Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment
- Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review
- Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes
- Non-pharmacological interventions on quality of life in stroke survivors: A systematic review and meta-analysis
- Natural products as the therapeutic strategies for addiction
- Defining the therapeutic relationship in the contexused in content analysis reviewt of alcohol use, other drug use, and behavior change: Principles and practices
- The effectiveness of the community reinforcement approach (CRA) in the context of quality of life and happiness among people using drugs
- Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence)
Evidence Blueprint
Municipal offers and principles for substitution treatment for abuse and addiction to opioids
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Municipal offers and principles for substitution treatment for abuse and addiction to opioids
🌐 365 Days
VR Related Evidence Matrix
- Stigma and level of familiarity with opioid maintenance treatment (OMT) among specialist physicians in Israel
- Who receives heroin-assisted treatment? A comparison of patients receiving opioid maintenance treatment in Denmark
- Blended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial
- Prescription high-risk polysubstance use among opioid maintenance treatment patients
- Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Depression and Suicidal Ideation among Patients Receiving Opioid Maintenance Treatments Considering Cognitive Flexibility
- Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder
- Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs
- Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study
- Change in self-reported somatic symptoms among patients in opioid maintenance treatment from baseline to 1-year follow-up
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment
- Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study
- An Appraisal of Using Opioids in Patients with Opioid Use Disorder
- Doing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States
- ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
- Evidence on Buprenorphine Dose Limits: A Review
- Kratom use disorder: case reports on successful treatment with home induction of buprenorphine-naloxone
- Sudden death during methadone replacement therapy - case report and literature review
- Adrenal Crisis Masked as Septic Shock in a Patient With Opioid Use Disorder on Buprenorphine
- The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Buprenorphine and Opioid Use Disorder Training: Graduate Nursing Curricula Recommendations
- Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder
- The effects of osteopathic manipulative treatment on pain and disability in patients with chronic low back pain: a single-blinded randomized controlled trial
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
- Patient Attitudes and Perceived Barriers Toward Mental Health Treatment Options in a Rural Student-Run Clinic
- A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy
- Buprenorphine/naloxone micro-induction in a tertiary care hospital: a retrospective cohort analysis
- Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder
- The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews
- Opioids in geriatric units in 14 Belgian hospitals: prevalence, dosage and associated factors
- Characterizing Acute and Postsurgical Pain Management in Patients Receiving Buprenorphine or Buprenorphine/naloxone
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- The association of medical providers' attitudes about naloxone and people with opioid use disorder and their self-reported "low-barrier" treatment practices
- Navigating Adherence: Unraveling Factors Shaping Opioid Substitution Therapy Compliance
- Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021
- Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest
- Methadone Withdrawal-Induced Psychosis: A Case Report
- Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder
- Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments
- Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
- Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective
- Are opioids effective analgesics and is physiological opioid dependence benign?: Revising current assumptions to effectively manage long-term opioid therapy and its deprescribing
- Reliability of urine drug testing among patients on buprenorphine transdermal patch
- Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act
- The End of the X-waiver: Excitement, Apprehension, and Opportunity
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder
- Damage to the nose and midface from cocaine abuse
- Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form
- Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers
- Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report
- Hospital-based opioid treatment: Expanding and sustaining the model in Texas
- Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report
- Impact of combination of intermittent theta burst stimulation and methadone maintenance treatment in individuals with opioid use disorder: A comparative study
- Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
- Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
- Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)